The article has been automatically translated into English by Google Translate from Russian and has not been edited.
Переклад цього матеріалу українською мовою з російської було автоматично здійснено сервісом Google Translate, без подальшого редагування тексту.
Bu məqalə Google Translate servisi vasitəsi ilə avtomatik olaraq rus dilindən azərbaycan dilinə tərcümə olunmuşdur. Bundan sonra mətn redaktə edilməmişdir.

Prices of COVID-19 vaccine from different companies announced

Moderna Inc plans to price its COVID-19 vaccine at between $ 50 and $ 60 per course, at least $ 11 more than vaccines from Pfizer Inc and BioNTech. Writes about it Reuters.

Photo: Shutterstock

Pfizer Inc and its German partner BioNTech agree to sell their vaccine to the US government for $ 39 per course (2 doses), significantly different from Moderna's price.

Industry analysts argued that the $ 2 billion deal with Pfizer and BioNTech, under which the US will receive 50 million doses of the vaccine, is likely to force other manufacturers to charge similar prices.

According to the announcement, Moderna's proposed price will apply to the United States and other high-income countries.

A Moderna spokesman said the company is in talks with governments for a possible delivery of a vaccine, dubbed mRNA-1273, but did not provide any detailed pricing data, "given the confidential nature of the discussions and contracts."

On the subject: Fighting COVID-19: How a Laboratory Works to Accelerate Vaccine Development for Years

The final price of Moderna's COVID-19 vaccine has yet to be determined, a person familiar with the situation said.

Pfizer, Moderna and Merck & Co have said they plan to sell their vaccines at a cost that will bring profit to the company, while several drug manufacturers, including Johnson & Johnson, have announced plans to price their vaccines on a non-profit basis.

AstraZeneca Plc has agreed to provide the United States with 300 million doses of its potential vaccine in exchange for $ 1,2 billion in pre-funding, which is $ 4 per dose.

The US government has provided nearly $ 1 billion in funding to Moderna to support research and development of a potential COVID-19 vaccine.

The funding is part of Operation Warp Speed, an initiative by the administration of President Donald Trump to accelerate production of the COVID-19 vaccine.

Miscellaneous vaccine Educational program coronavirus Special Projects

Read also on ForumDaily:

'Weakened version of the virus': scientists have found out how a person affects the SARS-CoV-2 mutation

Scientists have found out why the risk of contracting COVID-19 again is extremely low

US authorities order first 100 million doses of COVID-19 vaccine: vaccinated for free

'Safe and causes an immune response': already the second vaccine has been shown to be effective against COVID-19

Fighting COVID-19: How a Laboratory Works to Accelerate Vaccine Development for Years

Let's face the crisis together and support each other

Thank you for staying with us and trusting! Over the past 5 years, we have received a lot of grateful feedback from readers, whom our materials have helped to arrange life after moving to the USA. We have big plans, we don't want to stop or slow down the pace of work. Even now…

The COVID-19 pandemic has negatively affected our income, and in order to stay afloat, we have to ask YOU for support. We will be grateful for any amount and will make every effort to continue to publish news and a lot of useful information just as quickly.

Thank you for being with us!

Always yours, ForumDaily! WomanForumDaily, NewYork, ForumDaily!

Security of contributions is guaranteed by the use of the highly secure Stripe system.

Do you want more important and interesting news about life in the USA and immigration to America? Subscribe to our page in Facebook. Choose the "Display Priority" option and read us first. And don't forget to subscribe to ForumDaily Woman and ForumDaily New York - there you will find a lot of interesting and positive information.

1057 requests in 2,012 seconds.